Intus Biosciences Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 9

Employees
  • Latest Deal Type

  • Later Stage VC

  • Latest Deal Amount

  • $3.49M

  • Investors

  • 5

Intus Biosciences General Information

Description

Developer of assay and analysis platform designed to unlock the potential of the microbiome for healthcare. The company's kits leverage next-generation sequencing to identify microbiome imbalances in the gut through scalable and high-resolution capabilities, enabling patients to simultaneously resolve various microbial species.

Contact Information

Website
www.intusbio.com
Formerly Known As
Shoreline Biome
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 400 Farmington Avenue
  • CB119
  • Farmington, CT 06032
  • United States

Intus Biosciences Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intus Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 16-Nov-2022 $3.49M 000.00 Completed Generating Revenue
12. Later Stage VC 21-Jan-2022 00.00 00.000 Completed Generating Revenue
11. Later Stage VC 07-Jan-2021 00000 00.000 Completed Generating Revenue
10. Seed Round 27-May-2020 00.000 00.000 Completed Generating Revenue
9. Debt - PPP 07-Apr-2020 00.000 Completed Generating Revenue
8. Seed Round 14-Feb-2018 00.000 00.000 Completed Generating Revenue
7. Grant 01-Apr-2017 00000 00000 Completed Generating Revenue
6. Seed Round 31-May-2016 00000 00000 Completed Generating Revenue
5. Debt - General 06-May-2016 $295K Completed Generating Revenue
4. Seed Round $145K $295K Completed Generating Revenue
To view Intus Biosciences’s complete valuation and funding history, request access »

Intus Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of assay and analysis platform designed to unlock the potential of the microbiome for healthcare. The company'
Other Devices and Supplies
Farmington, CT
9 As of 2022
000.00
0000000000 0 000.00

0000 0

d tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, q
0000000000000
Epalinges, Switzerland
0 As of 0000
00.000
000000000 00.000

00000

it esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidata
0000000000 000000000
San Francisco, CA
00 As of 0000
000.00
000000 - 000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Intus Biosciences Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SEED Biosciences Venture Capital-Backed Epalinges, Switzerland 0 00.000 000000000 00.000
00000 Venture Capital-Backed San Francisco, CA 00 000.00 000000 - 000 000.00
000000 000000 Venture Capital-Backed Brisbane, CA 00 000.00 00000000000 000.00
0000000000 Venture Capital-Backed Chicago, IL 0 00.000 000000000 00.000
00000 (0000 000000 Formerly VC-backed Somerville, MA 00 00000 00000000 00000
You’re viewing 5 of 10 competitors. Get the full list »

Intus Biosciences Patents

  • 25

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Intus Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019263364-A1 Multiple specific/nonspecific primers for pcr of a complex gene pool Pending 04-May-2018 0000000000
CA-3095755-A1 Multiple specific/nonspecific primers for pcr of a complex gene pool Pending 04-May-2018 0000000000
EP-3788168-A1 Multiple specific/nonspecific primers for pcr of a complex gene pool Pending 04-May-2018 0000000000
EP-3788168-A4 Multiple specific/nonspecific primers for pcr of a complex gene pool Pending 04-May-2018 0000000000 0
US-20190352712-A1 Multiple specific/nonspecific primers for pcr of a complex gene pool Pending 04-May-2018 C12Q1/6876
To view Intus Biosciences’s complete patent history, request access »

Intus Biosciences Executive Team (5)

Name Title Board Seat Contact Info
Paul Denslow Co-Founder, Chief Executive Officer & Chairman
Mark Driscoll Ph.D Co-Founder, Chief Scientific Officer & Board Member
Alan Kersey Advisor
William McKenzie Advisor
You’re viewing 4 of 5 executive team members. Get the full list »

Intus Biosciences Board Members (8)

Name Representing Role Since
Alan Mendelson Self Board Member 000 0000
Frank Marco JD Wiggin and Dana Board Member 000 0000
Mark Driscoll Ph.D Intus Biosciences Co-Founder, Chief Scientific Officer & Board Member 000 0000
Matt Watson Self Board Member 000 0000
Paul Denslow Intus Biosciences Co-Founder, Chief Executive Officer & Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Intus Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intus Biosciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aimers Venture Partners Venture Capital Minority 000 0000 000000 0
VC23 Investors Venture Capital Minority 000 0000 000000 0
UConn Innovation Fund Venture Capital Minority 000 0000 000000 0
National Institute on Drug Abuse (NIDA) Government 000 0000 000000 0
Connecticut Innovations Venture Capital Minority 000 0000 000000 0
To view Intus Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial